[1] 马敬,王宁,石玉中.奥氮平与喹硫平治疗老年期精神病的临床观察[J].中国药房,2016,27(20):2827-2829.
[2] 袁梅,吴农艳,王俊龙,等.老年精神分裂症齐拉西酮与奥氮平治疗疗效及对血糖、血脂水平的影响[J].国际精神病学杂志,2015,42(2):29-32.
[3] Watanabe A, Fukui N, Suzkui Y, et al. Improvement of dumping syndrome and oversecretion of glucose-dependent insulinotropic polypeptide following a switch from olanzapine to quetiapine in a patient with schizophrenia [J]. Gen Hosp Psychiatry, 2015, 37(4): 272 e5-6.
[4] 中华医学会精神科分会.中国精神障碍分类与诊断标准(CGMD-3)[M].第3版.济南:山东科学技术出版社,2001:1-168.
[5] 何燕玲,张明园.阳性和阴性综合症量表(PANSS)及其应用[J].临床精神医学杂志,1999,7(6):353-355.
[6] 静芳,陶明,李翼群,等.智能筛选测验的信度和效度测试[J].中华精神科杂志,1997,30:175-178.
[7] Jang Y, Hsieh CL, Wang YH, et al. A validity study of the WHOQOL-BREF assessment in persons with traumatic spinal cord injury[J]. Arch Phys Med Rehabil,2004 85(11):1890-1895.
[8] 闫润涛,马晓燕,祖国平,等.富马酸喹硫平对首发精神分裂症患者睡眠脑电活动的影响[J].中华实用诊断与治疗杂志,2015,29(1):98-99.
[9] Vernal DL, Kapoor S, Al-Jadiri A, et al. Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study [J]. J Child Adolesc Psychopharmacol, 2015, 25(7): 535-547.
[10] Tomasik J, Schwarz E, Lago SG, et al. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients [J]. Brain Behav Immun, 2016, 52: 178-186.
[11] 卢喜金.阿立呱唑与喹硫平、奥氮平治疗精神分裂平激越行为的随机对照研究[J].中国现代医生,2013,51(17):81-83.
[12] 李文秀.抗精神病药物对精神分裂症患者社会功能影响及相关因素分析[J].海南医学院宵报,2013,19(1):136-138.
[13] Grunder G, Heinze M, Cordes J, et al. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study [J]. Lancet Psychiatry, 2016, 3(8): 717-729.
[14] 刘建君,孙菊水,沈鑫华,等.奎硫平对首发精神分裂症患者脑源性营养因子的影响[J].医药导报,2014,33(9):1185-1187. |
2017, Vol. 34 
